Cited by 1,011Inflammatory mediators and NSAID effectsReceptor Mechanisms and SignalingEicosanoids and Hypertension Pharmacology

The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.

Prostanoid Receptors: Subtypes and Signaling

Breyer, Richard M, Bagdassarian, Carey K, Myers, Scott A, Breyer, Matthew D·2001·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev.pharmtox.41.1.661

Open this paper in CoChat — free account

Abstract

Cyclooxygenases metabolize arachidonate to five primary prostanoids: PGE 2, PGF 2α, PGI 2, TxA 2, and PGD 2. These autacrine lipid mediators interact with specific members of a family of distinct G-protein-coupled prostanoid receptors, designated EP, FP, IP, TP, and DP, respectively. Each of these receptors has been cloned, expressed, and characterized. This family of eight prostanoid receptor complementary DNAs encodes seven transmembrane proteins which are typical of G-protein-coupled receptors and these receptors are distinguished by their ligand-binding profiles and the signal transduction pathways activated on ligand binding. Ligand-binding selectivity of these receptors is determined by both the transmembrane sequences and amino acid residues in the putative extracellular-loop regions. The selectivity of interaction between the receptors and G proteins appears to be mediated at least in part by the C-terminal tail region. Each of the EP 1, EP 3, FP, and TP receptors has alternative splice variants described that alter the coding sequence in the C-terminal intracellular tail region. The C-terminal variants modulate signal transduction, phosphorylation, and desensitization of these receptors, as well as altering agonist-independent constitutive activity.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.41.1.661

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,593
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,417
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,747
G Protein-coupled Receptors
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,281
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,169
The probable arrangement of the helices in G protein‐coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968
Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension
Tuder, R. M., Cool, C. D., Geraci, M. W., Wang, J., Abman, S. H., Wright, L. A., Badesch, D. B., & Voelkel, N. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9804054 · Cited by 804
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 679
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677
Failure of Parturition in Mice Lacking the Prostaglandin F Receptor
Sugimoto, Y., Yamasaki, A., Segi, E., Tsuboi, K., Aze, Y., Nishimura, T., Oida, H., Yoshida, N., Tanaka, T., Katsuyama, M., et al. (1997) · Science · doi:10.1126/science.277.5326.681 · Cited by 608
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.
Lewis, R. A., Soter, N. A., Diamond, P. T., Austen, K. F., Oates, J. A., & Roberts, L. J. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.4.1627 · Cited by 584
Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue
Hoeper, M. M., Schwarze, M., Ehlerding, S., Adler-Schuermeyer, A., Spiekerkoetter, E. F., Niedermeyer, J., Hamm, M. W., & Fabel, H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422503 · Cited by 566
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs
Abramovitz, M., Adam, M., Boie, Y., Carrière, M., Denis, D., Godbout, C., Lamontagne, S., Rochette, C., Sawyer, N., Tremblay, N. M., et al. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00164-x · Cited by 557
Prostanoid biosynthesis and mechanisms of action
Smith, W. L. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.263.2.f181 · Cited by 551
Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity
Namba, T., Sugimoto, Y., Negishi, M., Irie, A., Ushikubi, F., Kakizuka, A., Ito, S., Ichikawa, A., & Narumiya, S. (1993) · Nature · doi:10.1038/365166a0 · Cited by 543
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells
Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., & Narumiya, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701367 · Cited by 509
Dimerization of the δ Opioid Receptor:
Cvejic, S., & Devi, L. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26959 · Cited by 489
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype.
Honda, A., Sugimoto, Y., Namba, T., Watabe, A., Irie, A., Negishi, M., Narumiya, S., & Ichikawa, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53022-2 · Cited by 472
Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP 2
Hizaki, H., Segi‐Nishida, E., Sugimoto, Y., Hirose, M., Saji, T., Ushikubi, F., Matsuoka, T., Noda, Y., Tanaka, T., Yoshida, N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10501 · Cited by 467
G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets.
Offermanns, S., Laugwitz, K., Spicher, K., & Schultz, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.504 · Cited by 465
Prediction of Transmembrane Segments in Proteins Utilising Multiple Sequence Alignments
Persson, B. L., & Argos, P. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1220 · Cited by 460
Clinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809223191206 · Cited by 444
Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
Regan, J. W., Bailey, T. J., Pepperl, D. J., Pierce, K. L., Bogardus, A. M., Donello, J. E., Fairbairn, C., Kedzie, K. M., Woodward, D. F., & Gil, D. W. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09674-9 · Cited by 388
Cloning and expression of a cDNA for the human prostanoid FP receptor.
Abramovitz, M., Boie, Y., Nguyen, T., Rushmore, T. H., Bayne, M. A., Metters, K. M., Slipetz, D. M., & Grygorczyk, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41991-0 · Cited by 379
Clinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809153191106 · Cited by 378
Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor.
Watabe, A., Sugimoto, Y., Honda, A., Irie, A., Namba, T., Negishi, M., Ito, S., Narumiya, S., & Ichikawa, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80710-8 · Cited by 372
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth
Nguyen, M., Camenisch, T. D., Snouwaert, J. N., Hicks, E., Coffman, T. M., Anderson, P. A. W., Malouf, N. N., & Koller, B. H. (1997) · Nature · doi:10.1038/36342 · Cited by 361
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype.
Sugimoto, Y., Namba, T., Honda, A., Hayashi, Y., Negishi, M., Ichikawa, A., & Narumiya, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50448-3 · Cited by 357
Structural features required for ligand binding to the beta‐adrenergic receptor.
Dixon, R. A., Sigal, I. S., Candelore, M. R., Register, R. B., Scattergood, W., Rands, E., & Strader, C. D. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02645.x · Cited by 354
Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor.
Raychowdhury, M. K., Yukawa, M., Collins, L. J., McGrail, S. H., Kent, K. C., & Ware, J. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32161-0 · Cited by 353
Molecular Cloning and Characterization of the Human Prostanoid DP Receptor
Boie, Y., Sawyer, N., Slipetz, D. M., Metters, K. M., & Abramovitz, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18910 · Cited by 336
Patent Ductus Arteriosus and Neonatal Death in Prostaglandin Receptor EP4-Deficient Mice
Segi‐Nishida, E., Sugimoto, Y., Yamasaki, A., Aze, Y., Oida, H., Nishimura, T., Murata, T., Matsuoka, T., Ushikubi, F., Hirose, M., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8461 · Cited by 311
Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype.
Funk, C. D., Furci, L., FitzGerald, G. A., Grygorczyk, R., Rochette, C., Bayne, M. A., Abramovitz, M., Adam, M., & Metters, K. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74379-8 · Cited by 309
Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes
Boie, Y., Stocco, R., Sawyer, N., Slipetz, D. M., Ungrin, M., Neuschäfer‐Rube, F., Püschel, G. P., Metters, K. M., & Abramovitz, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01383-6 · Cited by 295
A novel inhibitory prostanoid receptor in piglet saphenous vein
Coleman, R. A., Grix, S. P., Head, S. A., Louttit, J. B., Mallett, A. I., & Sheldrick, R. L. G. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90084-1 · Cited by 268
cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla
Namba, T., Oida, H., Sugimoto, Y., Kakizuka, A., Negishi, M., Ichikawa, A., & Narumiya, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36979-x · Cited by 249
Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
Tilley, S. L., Audoly, L., Hicks, E., Kim, H., Flannery, P. J., Coffman, T. M., & Koller, B. H. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6579 · Cited by 249
Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype.
Bastien, L., Sawyer, N., Grygorczyk, R., Metters, K. M., & Adam, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32654-6 · Cited by 247
Segmental synthesis and actions of prostaglandins along the nephron
Bonvalet, J. P., Pradelles, P., & Farman, N. (1987) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1987.253.3.f377 · Cited by 247
Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers
Zeng, F., & Wess, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19487 · Cited by 247
Nuclear localization of prostaglandin E 2 receptors
Bhattacharya, M., Peri, K. G., Almazán, G., Ribeiro‐da‐Silva, A., Shichi, H., Durocher, Y., Abramovitz, M., Hou, X., Varma, D. R., & Chemtob, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15792 · Cited by 240
Localization of Functional Prostaglandin E2 Receptors EP3 and EP4 in the Nuclear Envelope
Bhattacharya, M., Peri, K. G., Ribeiro‐da‐Silva, A., Almazán, G., Shichi, H., Hou, X., Varma, D. R., & Chemtob, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15719 · Cited by 227
Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene.
Hirata, M., Kakizuka, A., Aizawa, M., Ushikubi, F., & Narumiya, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11192 · Cited by 224
In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs
Oida, H., Namba, T., Sugimoto, Y., Ushikubi, F., Ohishi, H., Ichikawa, A., & Narumiya, S. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15933.x · Cited by 223
Cloning and expression of a cDNA for mouse prostaglandin F receptor.
Sugimoto, Y., Hasumoto, K., Namba, T., Irie, A., Katsuyama, M., Negishi, M., Kakizuka, A., Narumiya, S., & Ichikawa, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42265-4 · Cited by 222
Two isoforms of the EP3 receptor with different carboxyl-terminal domains. Identical ligand binding properties and different coupling properties with Gi proteins.
Sugimoto, Y., Negishi, M., Hayashi, Y., Namba, T., Honda, A., Watabe, A., Hirata, M., Narumiya, S., & Ichikawa, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53832-1 · Cited by 212
Fetal immunization of baboons induces a fetal-specific antibody response
Watts, A. M., Stanley, J. R., Shearer, M. H., Hefty, P. S., & Kennedy, R. C. (1999) · Nature Medicine · doi:10.1038/7426 · Cited by 193
Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.
Nishigaki, N., Negishi, M., & Ichikawa, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09407-6 · Cited by 193
The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist
Giles, H., Leff, P., Bolofo, M. L., Kelly, M. G., & Robertson, A. D. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11816.x · Cited by 192
Cardiovascular Responses to the Isoprostanes iPF2α-III and iPE2-III Are Mediated via the Thromboxane A2Receptor In Vivo
Audoly, L., Rocca, B., Fabre, J., Koller, B. H., Thomas, D. W., Loeb, A. L., Coffman, T. M., & FitzGerald, G. A. (2000) · Circulation · doi:10.1161/01.cir.101.24.2833 · Cited by 192
Cloning and expression of a cDNA for the human prostanoid IP receptor.
Boie, Y., Rushmore, T. H., Darmon-Goodwin, A., Grygorczyk, R., Slipetz, D. M., Metters, K. M., & Abramovitz, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32697-2 · Cited by 192
Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder.
Hirata, T., Kakizuka, A., Ushikubi, F., Fuse, I., Okuma, M., & Narumiya, S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117510 · Cited by 191
Identification of Prostaglandin E2 as the Principal Vasodepressor Lipid of Rabbit Renal Medulla
Daniels, E. G., Hinman, J. W., Leach, B. E., & Muirhead, E. E. (1967) · Nature · doi:10.1038/2151298a0 · Cited by 181
Internalization of the TXA2 Receptor α and β Isoforms
Parent, J., Labrecque, P., Orsini, M. J., & Benovic, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8941 · Cited by 176
Third isoform of the prostaglandin‐E‐receptor EP3 subtype with different C‐terminal tail coupling to both stimulation and inhibition of adenylate cyclase
Irie, A., Sugimoto, Y., Namba, T., Harazono, A., HONDA, A., WATABE, A., Negishi, M., Narumiya, S., & Ichikawa, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18248.x · Cited by 173
p160 RhoA-binding Kinase ROKα Induces Neurite Retraction
Katoh, H., Aoki, J., Ichikawa, A., & Negishi, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2489 · Cited by 168
Constitutively Active Gα12, Gα13, and Gαq Induce Rho-dependent Neurite Retraction through Different Signaling Pathways
Katoh, H., Aoki, J., Yamaguchi, Y., Kitano, Y., Ichikawa, A., & Negishi, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28700 · Cited by 165
The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.
Kinsella, B. T., O’Mahony, D. J., & FitzGerald, G. A. (1997) · PubMed · Cited by 160
Mouse thromboxane A2 receptor: cDNA cloning, expression and Northern blot analysis
Namba, T., Sugimoto, Y., Hirata, M., Hayashi, Y., Honda, A., Watabe, A., Negishi, M., Ichikawa, A., & Narumiya, S. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80009-9 · Cited by 160
Prostaglandin D2 and sleep regulation
Urade, Y., & Hayaishi, O. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00163-5 · Cited by 159
The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and Northern blot analysis
Katsuyama, M., Nishigaki, N., Sugimoto, Y., Morimoto, K., Negishi, M., Narumiya, S., & Ichikawa, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00966-d · Cited by 156
Characterization of prostanoid relaxant/inhibitory receptors (ψ) using a highly selective agonist, TR4979
Gardiner, P. J. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb10155.x · Cited by 147
Cloning and Expression of the EP2 Subtype of Human Receptors for Prostaglandin E2
An, S. Z., Yang, J., Xia, M., & Goetzl, E. J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2470 · Cited by 146
Molecular evolution of receptors for eicosanoids
Toh, H., Ichikawa, A., & Narumiya, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00129-w · Cited by 143
Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor.
Guan, Y., Zhang, Y., BREYER, R. M., Fowler, B., Davis, L., Hébert, R., & Breyer, M. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2872 · Cited by 142
Self-citation
Identification of prostaglandin E receptor ‘EP2’ cloned from mastocytoma cells as EP4 subtype
Nishigaki, N., Negishi, M., Honda, A., Sugimoto, Y., Namba, T., Narumiya, S., & Ichikawa, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00421-5 · Cited by 139
Renal actions of prostacyclin
Bolger, P. M., Eisner, G. M., Ramwell, P. W., Slotkoff, L. M., & Corey, E. J. (1978) · Nature · doi:10.1038/271467a0 · Cited by 137
Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
Kotani, M., Tanaka, I., Ogawa, Y., Usui, T., Mori, K., Ichikawa, A., Narumiya, S., Yoshimi, T., & Nakao, K. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10545-2 · Cited by 134
Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney
Sugimoto, Y., Namba, T., Shigemoto, R., Negishi, M., Ichikawa, A., & Narumiya, S. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.5.f823 · Cited by 133
Differential Signaling by the Thromboxane Receptor Isoforms via the Novel GTP-binding Protein, Gh
Vezza, R., Habib, A., & FitzGerald, G. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12774 · Cited by 126
Splice Variants of the Human EP3 Receptor for Prostaglandin E2
Schmid, A., Thierauch, K., Schleuning, W.-D. D., & Dinter, H. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0023o.x · Cited by 120
Isoforms of the EP3 Subtype of Human Prostaglandin E2 Receptor Transduce Both Intracellular Calcium and cAMP Signals
An, S. M., Yang, J., SO, S. W., Zeng, L., & Goetzl, E. J. (1994) · Biochemistry · doi:10.1021/bi00252a016 · Cited by 119
Cloning and expression of three isoforms of the human EP3 prostanoid receptor
Adam, M., Boie, Y., Rushmore, T. H., Müller, G., Bastien, L., McKee, K. T., Metters, K. M., & Abramovitz, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80358-7 · Cited by 116
Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system.
Nakagawa, O., Tanaka, I., Usui, T., Harada, M., Sasaki, Y., Itoh, H., Yoshimasa, T., Namba, T., Narumiya, S., & Nakao, K. (1994) · Circulation · doi:10.1161/01.cir.90.4.1643 · Cited by 112
Activation of FP Prostanoid Receptor Isoforms Leads to Rho-mediated Changes in Cell Morphology and in the Cell Cytoskeleton
Pierce, K. L., Fujino, H., Srinivasan, D. K., & Regan, J. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35944 · Cited by 111
Two Isoforms of the Prostaglandin E Receptor EP3 Subtype Different in Agonist-independent Constitutive Activity
Hasegawa, H., Negishi, M., & Ichikawa, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1857 · Cited by 109
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli, T. A., Oatis, J. E., Okwu, A. K., Mais, D. E., Mayeux, P. R., Masuda, A., Knapp, D. R., & Halushka, P. V. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20844-8 · Cited by 107
Cloning of a Carboxyl-terminal Isoform of the Prostanoid FP Receptor
Pierce, K. L., Bailey, T. J., Hoyer, P. B., Gil, D. W., Woodward, D. F., & Regan, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.883 · Cited by 106
The α, but Not the β, Isoform of the Human Thromboxane A2 Receptor Is a Target for Prostacyclin-mediated Desensitization
Walsh, M., Foley, J. F., & Kinsella, B. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907881199 · Cited by 105
Cloning and expression of a cDNA for the human prostacyclin receptor
Katsuyama, M., Sugimoto, Y., Namba, T., Irie, A., Negishi, M., Narumiya, S., & Ichikawa, A. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00355-6 · Cited by 104
Differential localization of prostaglandin E receptor subtypes in human kidney
Breyer, M. D., Davis, L., Jacobson, H. R., & BREYER, R. M. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.5.f912 · Cited by 102
Self-citation
Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini
Regan, J. W., Bailey, T. J., Donello, J. E., Pierce, K. L., Pepperl, D. J., Zhang, D., Kedzie, K. M., Fairbairn, C., Bogardus, A. M., Woodward, D. F., et al. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13082.x · Cited by 101
Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization.
Abe, T., Takeuchi, K., Takahashi, N., TSUTSUMI, E., Taniyama, Y., & Abe, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118108 · Cited by 96
Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.
Funk, C. D., Furci, L., Moran, N. M., & FitzGerald, G. A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13289-6 · Cited by 94
Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor.
BREYER, R. M., Emeson, R. B., Jl, T., Breyer, M. D., Davis, L. S., Abromson, R. M., & Ferrenbach, S. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37583-x · Cited by 93
Self-citation
Urinary concentrating function in mice lacking EP3receptors for prostaglandin E2
Fleming, E. F., Athirakul, K., Oliverio, M. I., Key, M. L., Goulet, J. L., Koller, B. H., & Coffman, T. M. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.6.f955 · Cited by 92
Splice Variants of the Human EP3 Receptor for Prostaglandin E2
Schmid, A., Thierauch, K., Schleuning, W.-D. D., et al. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20223.x · Cited by 90
A new prostaglandin E receptor mediates calcium influx and acrosome reaction in human spermatozoa
Schaefer, M., Hofmann, T., Schultz, G., & Gudermann, T. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3008 · Cited by 89
Characterization of Murine Vasopressor and Vasodepressor Prostaglandin E2Receptors
Zhang, Y., Guan, Y., Schneider, A., Brandon, S., BREYER, R. M., & Breyer, M. D. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1129 · Cited by 87
Self-citation
Suppression of Prostaglandin E Receptor Signaling by the Variant Form of EP1 Subtype
Okuda‐Ashitaka, E., Sakamoto, K., Ezashi, T., Miwa, K., Ito, S., & Hayaishi, O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31255 · Cited by 86
Investigation of the prostaglandin E (EP‐) receptor subtype mediating relaxation of the rabbit jugular vein
Lawrence, R. A., & Jones, R. L. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09063.x · Cited by 85
Prostaglandin E2Receptor Subtype EP2Gene Expression in the Mouse Uterus Coincides with Differentiation of the Luminal Epithelium for Implantation1
Lim, H. J., & Dey, S. K. (1997) · Endocrinology · doi:10.1210/endo.138.11.5528 · Cited by 85
Selective Coupling of Prostaglandin E Receptor EP3D to Gi and Gs through Interaction of α-Carboxylic Acid of Agonist and Arginine Residue of Seventh Transmembrane Domain
Negishi, M., Irie, A., Sugimoto, Y., Namba, T., & Ichikawa, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16122 · Cited by 79
Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: involvement of EP1 and EP3 receptor subtypes
Asbóth, G., Phaneuf, S., Europe‐Finner, G. N., Tóth, M., & Bernal, A. L. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641211 · Cited by 78
Molecular Cloning and Intrarenal Localization of Rat Prostaglandin E2 Receptor EP3 Subtype
Takeuchi, K., Abe, T., Takahashi, N., & Abe, K. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1904 · Cited by 76
In situ hybridization and localization of mRNA for the rabbit prostaglandin EP3 receptor
Breyer, M. D., Jacobson, H. R., Davis, L. S., & BREYER, R. M. (1993) · Kidney International · doi:10.1038/ki.1993.391 · Cited by 76
Self-citation
Molecular Cloning and Expression of a Rat Prostaglandin E2 Receptor of the EP2 Subtype
Nemoto, K., Pilbeam, C. C., Bilak, S. R., & Raisz, L. G. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00145-7 · Cited by 75
N-Substituted dibenzoxazepines as analgesic PGE2 antagonists
Hallinan, E. A., Hagen, T. J., Husa, R. K., Tsymbalov, S., Rao, S., VANHOECK, J. ‐., Rafferty, M. F., Stapelfeld, A., Savage, M. A., & Reichman, M. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00074a010 · Cited by 75
Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma.
Pavord, I. D., Wisniewski, A. F. Z., Mathur, R., Wahedna, I., Knox, A. J., & Tattersfield, A. (1991) · Thorax · doi:10.1136/thx.46.9.633 · Cited by 73
Prostaglandin E Receptor EP3 Subtype Induces Neurite Retraction via Small GTPase Rho
Katoh, H., Negishi, M., & Ichikawa, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29780 · Cited by 72
Cloning and Expression of the EP3-Subtype of Human Receptors for Prostaglandin E2
Yang, J., Xia, M., Goetzl, E. J., & An, S. Z. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1142 · Cited by 72
8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid,2-[3-[2-(furanylmethyl)thio]-1-oxopropyl]hydrazide (SC-51322): A potent PGE2 antagonist and analgesic
Hallinan, E. A., Stapelfeld, A., Savage, M. A., & Reichman, M. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(94)80027-8 · Cited by 69
Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa
Ito, S., Carretero, O. A., Abe, K., Beierwaltes, W. H., & YOSHINAGA, K. (1989) · Kidney International · doi:10.1038/ki.1989.102 · Cited by 67
Molecular Cloning and Expression of Rat Prostaglandin E Receptor EP2 Subtype
Sando, T., Usui, T., Tanaka, I., Mori, K., Sasaki, Y., Fukuda, Y., Namba, T., Sugimoto, Y., Ichikawa, A., Narumiya, S., et al. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1596 · Cited by 65
A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor
Wright, D. H., Nantel, F., Metters, K. M., & Ford‐Hutchinson, A. W. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00358-1 · Cited by 62
The Second Extracellular Loop of the Prostaglandin EP3 Receptor Is an Essential Determinant of Ligand Selectivity
Audoly, L., & BREYER, R. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13475 · Cited by 61
Self-citation
Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogs
Schaaf, T. K., & Hess, H. J. (1979) · Journal of Medicinal Chemistry · doi:10.1021/jm00197a012 · Cited by 61
Expression of messenger RNA for the prostaglandin D receptor in the leptomeninges of the mouse brain
Oida, H., Hirata, M., Sugimoto, Y., Ushikubi, F., Ohishi, H., Mizuno, N., ICHIKAWA, A., & Narumiya, S. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01253-2 · Cited by 60
Constitutive activity of human prostaglandin E receptor EP3 isoforms
Jin, J., Mao, G. F., & Ashby, B. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701121 · Cited by 59
Cloning and expression of the rabbit prostaglandin EP4 receptor
BREYER, R. M., Davis, L. S., Nian, C., Redha, R., Stillman, B. A., Jacobson, H. R., & Breyer, M. D. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.3.f485 · Cited by 57
Self-citation
Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery
Lydford, S. J., McKechnie, K. C. W., & Dougall, I. G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15148.x · Cited by 57
Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats
Kantha, S. S., Matsumura, H., Kubo, E., Kawase, K., Takahata, R., Serhan, C. N., & Hayaishi, O. (1994) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(94)90083-3 · Cited by 56
Mutagenic Analysis of Platelet Thromboxane Receptor Cysteines
D’Angelo, D. D., Eubank, J. J., Davis, M. G., & Dorn, G. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6233 · Cited by 54
Thromboxane receptor blockade reduces renal injury in murine lupus nephritis
Spurney, R. F., Fan, P.-Y., Ruiz, P., Sanfilippo, F. P., Pisetsky, D. S., & Coffman, T. M. (1992) · Kidney International · doi:10.1038/ki.1992.149 · Cited by 51
The Long Cytoplasmic Carboxyl Terminus of the Prostaglandin E2 Receptor EP4 Subtype Is Essential for Agonist-Induced Desensitization
Bastepe, M., & Ashby, B. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.2.343 · Cited by 48
Substitution of Charged Amino Acid Residues in Transmembrane Regions 6 and 7 Affect Ligand Binding and Signal Transduction of the Prostaglandin EP3 Receptor
Audoly, L., & BREYER, R. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.1.61 · Cited by 47
Self-citation
A conserved threonine in the second extracellular loop of the human EP2 and EP4 receptors is required for ligand binding
Stillman, B. A., Audoly, L., & BREYER, R. M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00522-6 · Cited by 47
Self-citation
Cloning and expression of a cDNA for rat prostaglandin F2α receptor
Kitanaka, J., Hasimoto, H., Aino, H., Gotoh, M., Baba, A., Sugimoto, Y., Negishi, M., & Ichikawa, A. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90094-9 · Cited by 45
Differential Regulation of Prostaglandin F2 Receptor Isoforms by Protein Kinase C
Fujino, H., Srinivasan, D. K., Pierce, K. L., & Regan, J. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23207-7 · Cited by 44
Differential regulation of prostaglandin F(2alpha) receptor isoforms by protein kinase C.
Fujino, H., Srinivasan, D. K., Pierce, K. L., et al. (2000) · PubMed · Cited by 42
SC-46275: A potent and highly selective agonist at the EP3 receptor
Savage, M. A., Moummi, C., Karabatsos, P. J., & Lanthorn, T. H. (1993) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(93)90179-z · Cited by 36
Signal transduction pathway regulating prostaglandin EP3 receptor-induced neurite retraction: requirement for two different tyrosine kinases
Aoki, J., Katoh, H., Yasui, H., Yamaguchi, Y., Nakamura, K., Hasegawa, H., Ichikawa, A., & Negishi, M. (1999) · Biochemical Journal · doi:10.1042/bj3400365 · Cited by 35
Amino Acid Residues Conferring Ligand Binding Properties of Prostaglandin I and Prostaglandin D Receptors
Kobayashi, T., Ushikubi, F., & Narumiya, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002437200 · Cited by 35
Functional interaction of prostaglandin E receptor EP3 subtype with guanine nucleotide-binding proteins, showing low-affinity ligand binding
Negishi, M., Sugimoto, Y., Hayashi, Y., Namba, T., Honda, A., Watabe, A., Narumiya, S., & Ichikawa, A. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90227-g · Cited by 35
A Single Amino-Acid Substitution in the EP2Prostaglandin Receptor Confers Responsiveness to Prostacyclin Analogs
Kedzie, K. M., Donello, J. E., Krauss, H. A., Regan, J. W., & Gil, D. W. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.584 · Cited by 34
Identification of a region of the C‐terminal domain involved in short‐term desensitization of the prostaglandin EP4 receptor
Bastepe, M., & Ashby, B. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702291 · Cited by 31
Different membrane targeting of prostaglandin EP3 receptor isoforms dependent on their carboxy‐terminal tail structures
Hasegawa, H., Katoh, H., Yamaguchi, Y., Nakamura, K., Futakawa, S., & Negishi, M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01508-8 · Cited by 30
The Role of N-Glycosylation of Human Thromboxane A2Receptor in Ligand Binding
Chiang, N., & Tai, H. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0620 · Cited by 30
Prostaglandin E2 Receptor Subtype EP2 Gene Expression in the Mouse Uterus Coincides with Differentiation of the Luminal Epithelium for Implantation
Lim, H. J. (1997) · Endocrinology · doi:10.1210/en.138.11.4599 · Cited by 30
Molecular cloning and expression of a prostaglandin E2 receptor of the EP3β subtype from rat hepatocytes
Neuschäfer‐Rube, F., DeVries, C., Hänecke, K., Jungermann, K. A., & Püschel, G. P. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00837-x · Cited by 29
Classification of platelet and vascular prostaglandin D2 (DP) receptors: estimation of affinities and relative efficacies for a series of novel bicylic ligands With an Appendix on Goodness‐of‐fit analyses
Leff, P., & Giles, H. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14447.x · Cited by 29
Increased renal formation of thromboxane A 2 and prostaglandin F 2α in heart failure
Castellani, S., Paladini, B., Paniccia, R., Serio, C. D., Vallotti, B., Ungar, A., Fumagalli, S., Cantini, C., Poggesi, L., & Serneri, G. G. N. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70253-9 · Cited by 28
A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptors
Wise, H. M., Qian, Y., & Jones, R. L. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00173-i · Cited by 27
Prostaglandin E-Prostanoid-3 Receptor Activation of Cyclic AMP Response Element-Mediated Gene Transcription
Audoly, L., Ma, L., Feoktistov, I., de Foe, S. K., Breyer, M. D., & Breyer, R. M. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38116-9 · Cited by 27
Self-citation
Importance of the Extracellular Domain for Prostaglandin EP2Receptor Function
Stillman, B. A., Breyer, M. D., & BREYER, R. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.3.545 · Cited by 27
Self-citation
Detection and quantitation of EP3 prostaglandin E2 receptor mRNA along mouse nephron segments by RT-PCR
Taniguchi, S., Watanabe, T., Nakao, A., Seki, G., Uwatoko, S., & Kurokawa, K. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.5.c1453 · Cited by 26
Functional interaction of the carboxylic acid group of agonists and the arginine residue of the seventh transmembrane domain of prostaglandin E receptor EP3 subtype
Chang, C.-S., Negishi, M., Nishigaki, N., & Ichikawa, A. (1997) · Biochemical Journal · doi:10.1042/bj3220597 · Cited by 25
Possible role for ligand binding of histidine 81 in the second transmembrane domain of the rat prostaglandin F 2α receptor
Rehwald, M., Neuschäfer‐Rube, F., de Vries, C., & Püschel, G. P. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00007-1 · Cited by 25
Functional Difference between Two Isoforms of Rat Kidney Prostaglandin Receptor EP3 Subtype
Takeuchi, K., Takahashi, N., Abe, T., Ito, O., Tsutsumi, E., Taniyama, Y., & Abe, K. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2409 · Cited by 25
Activation of Mitogen-Activated Protein Kinase by the Human Prostaglandin EP3A Receptor
Burkey, T. H., & Regan, J. W. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1790 · Cited by 25
Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of KATP-channels
Zacharowski, K. D., Olbrich, A., & Thiemermann, C. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00963-7 · Cited by 24
Coupling of thromboxane A2 receptor isoforms to Gα13: effects on ligand binding and signalling
Becker, K. P., Garnovskaya, M. N., Gettys, T. W., & Halushka, P. V. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00068-3 · Cited by 22
Thromboxane A2/ prostaglandin H2 receptors in streptozotocin-induced diabetes: Effects of insulin therapy in the rat
Morinelli, T. A., Tempel, G. E., Jaffa, A. A., Silva, R. H., Naka, M., Folger, W. H., & Halushka, P. V. (1993) · Prostaglandins · doi:10.1016/0090-6980(93)90119-r · Cited by 20
Changes in Membrane and Surface Potential Explain the Opposite Effects of Low Ionic Strength on the Two Lysine Transporters of Human Erythrocytes
Devés, R., & Angelo, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32034 · Cited by 18
Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid
Tsai, B. S., Kessler, L. K., Stolzenbach, J. C., Schoenhard, G. L., & Bauer, R. F. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01297024 · Cited by 14
Relation between renin release and blood pressure response to nonsteroidal anti-inflammatory drugs in hypertension.
Jackson, E. K. (1989) · Hypertension · doi:10.1161/01.hyp.14.5.469 · Cited by 14
EP1 receptor antagonist blocks the diarrheagenic, but not cytoprotective, actions of a synthetic prostaglandin
Lanthorn, T. H., Bianchi, R. G., & Perkins, W. E. (1995) · Drug Development Research · doi:10.1002/ddr.430340106 · Cited by 13
Stimulation of renin release by PGE2and PGI2infusion in the dog: enhancing effect of ureteral occlusion or administration of ethacrynic acid
Bugge, J. F., STOKKE, E. S., VIKSE, A., & Kiil, F. (1990) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1990.tb08833.x · Cited by 13
Partial agonist effects of BW A868C, a selective DP receptor antagonist, on Cl− secretion in dog tracheal epithelium
Liu, Y. J., Jackson, D. M., Blackham, A., & Leff, P. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00129-x · Cited by 12
Cloning and characterization of an endogenous COS-7 cell thromboxane A2 receptor
Becker, K. P., Ullian, M. E., & Halushka, P. V. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00019-6 · Cited by 12
Prostanoid receptor with a novel pharmacological profile in human erythroleukemia cells
Feoktistov, I., BREYER, R. M., & Biaggioni, I. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00288-8 · Cited by 12
Self-citation
Analysis of a porcine EP3-receptor: cloning, expression and signal transduction
Meyer-Kirchrath, J., Kuger, P., Hohlfeld, T., & Schrör, K. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005238 · Cited by 9
SC-46275: a potent, long-acting gastric antisecretory prostaglandin with low oral bioavailability in the dog.
Perkins, W. E., Burton, E. G., Tsai, B. S., Collins, P. W., Casler, J. J., Gasiecki, A. F., Bauer, R. F., Jones, P. H., & Gaginella, T. S. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20442-6 · Cited by 7

Research works printed but not linked: 18

Coleman RA, 1994, Pharmacol. Rev., 46, 205
Leach AR. 1996.Molecular Modelling. Essex, England: Longman Ltd.pp. 25–90
Kolakowski L, 1994, Mol. Pharmacol. Recept. Channels, 2, 1
Morinelli TA, 1989, J. Pharmacol. Exp. Ther., 251, 557
Kinsella BT, 1997, J. Pharmacol. Exp. Ther., 281, 957
Funk CD, 1993, Mol. Pharmacol., 44, 934
Sakamoto K, 1994, J. Biol. Chem., 5, 3381
Fujino H, 2000, Mol. Pharmacol., 57, 353
Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P. 1990.Prostanoids and their receptors.InComprehensive Medicinal Chemistry, ed. JC Emmet, pp. 643–714. Oxford, UK: Pergamon
Abramovitz M, 1995, Adv. Prostaglandin Thromboxane Leukot. Res., 23, 499
Regan JW, 1994, Mol. Pharmacol., 46, 213
Guan Y, 1996, J. Am. Soc. Nephrol, 7, 1646
Nishigaki N, 1996, Mol. Pharmacol., 50, 1031
Perkins W, 1991, J. Pharmacol. Exp. Ther., 259, 1004
10.1042/0264-6021:3400365 · DOI
Audoly L, 1999, J. Pharmacol. Exp. Ther., 289, 140
Edwards RM, 1985, Am. J. Physiol., 248, F779
Kotani M, 1995, Mol. Pharmacol., 48, 869

Sorted by citations

Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 4,035
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 2,075
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Zheng, W., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,538
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D. M., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,168
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R. N., Chin, K., Frey, A., Gaine, S., Galiè, N., Ghofrani, H. A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,062

See all 1,011

Authors: Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D.
Affiliations: United States Department of Veterans Affairs (US)
ORCID: Breyer, Richard M
Breyer, Matthew D
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2001-04
Volume: 41
Issue: 1
Pages: 661-690
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev.pharmtox.41.1.661
OpenAlex: W2129746956
Cited by: 1,011
References: 152
Citations by year: 2026: 7 · 2025: 17 · 2024: 11 · 2023: 22 · 2022: 17 · 2021: 27 · 2020: 37 · 2019: 22 · 2018: 24 · 2017: 32 · 2016: 38 · 2015: 43 · 2014: 50 · 2013: 40 · 2012: 51
FWCI: 5.37
Type: journal article
Language: en
Open access: closed
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of General Medical Sciences (GM 15431)
National Institute of Diabetes and Digestive and Kidney Diseases (DK37097, DK46205, R01DK037097, R01DK046205)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords: prostanoid receptors, G protein-coupled receptors, prostaglandins, cyclooxygenase, arachidonic acid metabolism, prostaglandin E2, prostaglandin F2alpha, prostacyclin, thromboxane A2, prostaglandin D2, receptor subtypes, ligand selectivity, splice variants, receptor desensitization, receptor phosphorylation, constitutive receptor activity, signal transduction
MeSH terms: Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Prostaglandins, Receptors, Prostaglandin, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prostanoid Receptors: Subtypes and Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks